Signal transduction by protease‐activated receptors
暂无分享,去创建一个
[1] J. Trejo,et al. Phosphorylation of Protease-activated Receptor-2 Differentially Regulates Desensitization and Internalization* , 2009, The Journal of Biological Chemistry.
[2] M. Hollenberg,et al. Agonist-Biased Signaling via Proteinase Activated Receptor-2: Differential Activation of Calcium and Mitogen-Activated Protein Kinase Pathways , 2009, Molecular Pharmacology.
[3] M. Hung,et al. Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis* , 2009, The Journal of Biological Chemistry.
[4] G. Cottrell,et al. Endosomal Deubiquitinating Enzymes Control Ubiquitination and Down-regulation of Protease-activated Receptor 2* , 2009, The Journal of Biological Chemistry.
[5] J. Trejo,et al. Thrombin Promotes Release of ATP from Lung Epithelial Cells through Coordinated Activation of Rho- and Ca2+-dependent Signaling Pathways* , 2009, The Journal of Biological Chemistry.
[6] V. Trivedi,et al. Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site , 2009, Cell.
[7] J. Trejo,et al. Caveolae are required for protease-selective signaling by protease-activated receptor–1 , 2009, Proceedings of the National Academy of Sciences.
[8] P. Sexton,et al. Modulating receptor function through RAMPs: can they represent drug targets in themselves? , 2009, Drug discovery today.
[9] J. Trejo,et al. Proteases display biased agonism at protease-activated receptors: location matters! , 2009, Molecular interventions.
[10] C. Flordellis,et al. Parstatin, the Cleaved Peptide on Proteinase-Activated Receptor 1 Activation, Is a Potent Inhibitor of Angiogenesis , 2009, Journal of Pharmacology and Experimental Therapeutics.
[11] Raymond C Stevens,et al. Discovery of new GPCR biology: one receptor structure at a time. , 2009, Structure.
[12] C. Brinckerhoff,et al. Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. , 2008, The American journal of pathology.
[13] S. Emr,et al. Arrestin-Related Ubiquitin-Ligase Adaptors Regulate Endocytosis and Protein Turnover at the Cell Surface , 2008, Cell.
[14] H. Pelham,et al. Arrestin-like proteins mediate ubiquitination and endocytosis of the yeast metal transporter Smf1 , 2008, EMBO reports.
[15] M. Hollenberg,et al. Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction , 2008, Journal of Biological Chemistry.
[16] A. Tobin,et al. Location, location, location…site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling , 2008, Trends in pharmacological sciences.
[17] C. E. Alvarez. On the origins of arrestin and rhodopsin , 2008, BMC Evolutionary Biology.
[18] M. Yepes,et al. Plasmin Potentiates Synaptic N-Methyl-D-aspartate Receptor Function in Hippocampal Neurons through Activation of Protease-activated Receptor-1* , 2008, Journal of Biological Chemistry.
[19] P. Cullen. Endosomal sorting and signalling: an emerging role for sorting nexins , 2008, Nature Reviews Molecular Cell Biology.
[20] W. Greenlee,et al. Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. , 2008, Journal of medicinal chemistry.
[21] T. Hökfelt,et al. Postendocytotic traffic of the galanin R1 receptor: A lysosomal signal motif on the cytoplasmic terminus , 2008, Proceedings of the National Academy of Sciences.
[22] J. Chun,et al. Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation , 2008, Nature.
[23] J. Niu,et al. Zyxin is involved in thrombin signaling via interaction with PAR‐1 receptor , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] J A Peters,et al. Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.
[25] A. Marchese,et al. G protein-coupled receptor sorting to endosomes and lysosomes. , 2008, Annual review of pharmacology and toxicology.
[26] M. von Zastrow,et al. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. , 2008, Annual review of pharmacology and toxicology.
[27] C. Derian,et al. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage , 2007, Nature Immunology.
[28] J. Bae,et al. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. , 2007, Blood.
[29] A. Malik,et al. Dual Regulation of Endothelial Junctional Permeability , 2007, Science's STKE.
[30] R. Piper,et al. Biogenesis and function of multivesicular bodies. , 2007, Annual review of cell and developmental biology.
[31] G. Reiser,et al. p24A, a Type I Transmembrane Protein, Controls ARF1-dependent Resensitization of Protease-activated Receptor-2 by Influence on Receptor Trafficking* , 2007, Journal of Biological Chemistry.
[32] G. Cottrell,et al. Hepatocyte Growth Factor-regulated Tyrosine Kinase Substrate (HRS) Mediates Post-endocytic Trafficking of Protease-activated Receptor 2 and Calcitonin Receptor-like Receptor* , 2007, Journal of Biological Chemistry.
[33] A. Marchese,et al. Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1 , 2007, The Journal of cell biology.
[34] U. Pendurthi,et al. Modulation of Tissue Factor–Factor VIIa Signaling by Lipid Rafts and Caveolae , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[35] J. Trejo,et al. Clathrin‐Dependent Mechanisms of G Protein‐coupled Receptor Endocytosis , 2007, Traffic.
[36] S. Ferguson. Phosphorylation-independent attenuation of GPCR signalling. , 2007, Trends in pharmacological sciences.
[37] A. Malik,et al. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization , 2007, Proceedings of the National Academy of Sciences.
[38] J. Bae,et al. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells , 2007, Proceedings of the National Academy of Sciences.
[39] S. Milano,et al. Regulation of receptor trafficking by GRKs and arrestins. , 2007, Annual review of physiology.
[40] Arthur Christopoulos,et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.
[41] M. Amorim,et al. Nuclear Export of Influenza A Virus mRNAs Requires Ongoing RNA Polymerase II Activity , 2007, Traffic.
[42] V. Gurevich,et al. The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. , 2006, Pharmacology & therapeutics.
[43] J. Bonifacino,et al. The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain , 2006, Nature Structural &Molecular Biology.
[44] D. Siderovski,et al. Clathrin Adaptor AP2 Regulates Thrombin Receptor Constitutive Internalization and Endothelial Cell Resensitization , 2006, Molecular and Cellular Biology.
[45] G. Reiser,et al. Jab1, a Novel Protease-activated Receptor-2 (PAR-2)-interacting Protein, Is Involved in PAR-2-induced Activation of Activator Protein-1* , 2006, Journal of Biological Chemistry.
[46] T. Magnuson,et al. An essential role for SNX1 in lysosomal sorting of protease-activated receptor-1: evidence for retromer-, Hrs-, and Tsg101-independent functions of sorting nexins. , 2005, Molecular biology of the cell.
[47] S. Coughlin,et al. Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.
[48] H. Hamm,et al. Functional Selectivity of G Protein Signaling by Agonist Peptides and Thrombin for the Protease-activated Receptor-1*[boxs] , 2005, Journal of Biological Chemistry.
[49] J. Garcia,et al. Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement , 2005, Journal of Biological Chemistry.
[50] Robert J. Lefkowitz,et al. Transduction of Receptor Signals by ß-Arrestins , 2005, Science.
[51] G. Cottrell,et al. c-Cbl Mediates Ubiquitination, Degradation, and Down-regulation of Human Protease-activated Receptor 2* , 2005, Journal of Biological Chemistry.
[52] C. Feistritzer,et al. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.
[53] V. Jala,et al. Phosphorylation-independent β-Arrestin Translocation and Internalization of Leukotriene B4 Receptors* , 2005, Journal of Biological Chemistry.
[54] J. Trejo,et al. Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking , 2005, Molecular Pharmacology.
[55] R. Lefkowitz,et al. Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2* , 2004, Journal of Biological Chemistry.
[56] Judith Klumperman,et al. Sorting Nexin-1 Mediates Tubular Endosome-to-TGN Transport through Coincidence Sensing of High- Curvature Membranes and 3-Phosphoinositides , 2004, Current Biology.
[57] J. Trejo,et al. A Tyrosine-based Sorting Signal Regulates Intracellular Trafficking of Protease-activated Receptor-1 , 2004, Journal of Biological Chemistry.
[58] M. Laburthe,et al. Protease-activated Receptor 2 in Colon Cancer , 2004, Journal of Biological Chemistry.
[59] S. Coughlin,et al. Regulated Shedding of PAR1 N-terminal Exodomain from Endothelial Cells* , 2004, Journal of Biological Chemistry.
[60] J. Trejo,et al. Termination of Protease-activated Receptor-1 Signaling by β-Arrestins Is Independent of Receptor Phosphorylation* , 2004, Journal of Biological Chemistry.
[61] J. Bonifacino,et al. Signals for sorting of transmembrane proteins to endosomes and lysosomes. , 2003, Annual review of biochemistry.
[62] D. Roosterman,et al. Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2. , 2003, American journal of physiology. Cell physiology.
[63] W. Ruf,et al. Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.
[64] C. Haft,et al. Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. , 2002, Molecular biology of the cell.
[65] H. Hamm,et al. Aspartic Acid 564 in the Third Cytoplasmic Loop of the Luteinizing Hormone/Choriogonadotropin Receptor Is Crucial for Phosphorylation-independent Interaction with Arrestin2* , 2002, The Journal of Biological Chemistry.
[66] T. Kohout,et al. β-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation* , 2002, The Journal of Biological Chemistry.
[67] G. Christ,et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.
[68] V. Mahajan,et al. Thrombin Receptor Signaling to Cytoskeleton Requires Hsp90* , 2001, The Journal of Biological Chemistry.
[69] D. Morrison,et al. Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[70] R. Scarborough,et al. Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide. , 2000, Molecular pharmacology.
[71] P. Nurden,et al. The Cleaved Peptide of PAR1 Results in a Redistribution of the Platelet Surface GPIb-IX-V Complex to the Surface-Connected Canalicular System , 2000, Thrombosis and Haemostasis.
[72] V. Mahajan,et al. Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[73] S. Coughlin,et al. Protease-activated Receptor-1 Down-regulation , 2000, The Journal of Biological Chemistry.
[74] M. Furman,et al. GPIIb-IIIa Antagonist-induced Reduction in Platelet Surface Factor V/Va Binding and Phosphatidylserine Expression in Whole Blood , 2000, Thrombosis and Haemostasis.
[75] S. Coughlin,et al. Protease-activated Receptors 1 and 4 Are Shut Off with Distinct Kinetics after Activation by Thrombin* , 2000, The Journal of Biological Chemistry.
[76] A. Malik,et al. G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[77] N. Prévost,et al. Thrombin Responses in Human Endothelial Cells , 2000, The Journal of Biological Chemistry.
[78] S. Coughlin,et al. PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.
[79] R. Mullins,et al. β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.
[80] N. Bunnett,et al. Trafficking of Proteinase-activated Receptor-2 and β-Arrestin-1 Tagged with Green Fluorescent Protein , 1999, The Journal of Biological Chemistry.
[81] P. Sigler,et al. A Model for Arrestin’s Regulation: The 2.8 Å Crystal Structure of Visual Arrestin , 1999, Cell.
[82] C. Costello,et al. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. , 1999, Biochemistry.
[83] Jie Zhang,et al. The β2-adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis , 1999 .
[84] S. Coughlin,et al. The Cytoplasmic Tails of Protease-activated Receptor-1 and Substance P Receptor Specify Sorting to Lysosomes versusRecycling* , 1999, The Journal of Biological Chemistry.
[85] S. Coughlin,et al. Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[86] M. Grossmann,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[87] D. Payan,et al. Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* , 1996, The Journal of Biological Chemistry.
[88] A. Roth,et al. Ubiquitination of the yeast a-factor receptor , 1996, The Journal of cell biology.
[89] S. Coughlin,et al. Agonist Recognition by Proteinase-activated Receptor 2 and Thrombin Receptor , 1996, The Journal of Biological Chemistry.
[90] A. Ullrich,et al. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.
[91] Howard Riezman,et al. Ubiquitination of a Yeast Plasma Membrane Receptor Signals Its Ligand-Stimulated Endocytosis , 1996, Cell.
[92] B. Kobilka,et al. Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. , 1994, The Journal of biological chemistry.
[93] J. Chen,et al. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. , 1994, The Journal of biological chemistry.
[94] N. Nathanson,et al. Differential role of the carboxyl-terminal tyrosine in down-regulation and sequestration of the m2 muscarinic acetylcholine receptor. , 1994, The Journal of biological chemistry.
[95] C. Turck,et al. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface , 1994, Nature.
[96] J. Chen,et al. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. , 1994, The Journal of biological chemistry.
[97] B. Kobilka,et al. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. , 1993, The Journal of biological chemistry.
[98] V. Wheaton,et al. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. , 1992, The Journal of biological chemistry.
[99] M. Caron,et al. Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. , 1992, Biochemistry.
[100] V. Wheaton,et al. Domains specifying thrombin–receptor interaction , 1991, Nature.
[101] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[102] J. Ramachandran,et al. Structure and Function of G Protein Coupled Receptors , 1990, Pharmaceutical Research.
[103] M. Caron,et al. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.
[104] H. Hamm,et al. Heterotrimeric G protein activation by G-protein-coupled receptors , 2008, Nature Reviews Molecular Cell Biology.
[105] H. Hamm,et al. How do receptors activate G proteins? , 2007, Advances in protein chemistry.
[106] David Owen,et al. Life of a clathrin coat: insights from clathrin and AP structures , 2006, Nature Reviews Molecular Cell Biology.
[107] J. Griffin,et al. bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. The cytoprotective protein C pathway , 2006 .
[108] J. Griffin,et al. Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. , 2004, Blood.
[109] M. Hollenberg,et al. Proteinase-activated receptor-2: key role of amino-terminal dipeptide residues of the tethered ligand for receptor activation. , 2004, Molecular pharmacology.
[110] S. Coughlin,et al. PARticipation in inflammation. , 2003, The Journal of clinical investigation.
[111] J. Reny,et al. Hemostasis, Thrombosis, and Vascular Biology , 2022 .
[112] S. Coughlin,et al. A MUTANT HeLa CELL LINE SUGGESTS NOVEL REQUIREMENTS FOR PAR1 PHOSPHORYLATION AND RECRUITMENT TO CLATHRIN-COATED PITS* , 2000 .
[113] A. Ullrich,et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.
[114] P. Sigler,et al. The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. , 1999, Cell.
[115] J. Benovic,et al. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.
[116] J. Benovic,et al. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.
[117] E. Simons,et al. Thrombin receptors on human platelets. , 1992, Methods in enzymology.
[118] S. Coughlin,et al. PAR 3 is a cofactor for PAR 4 activation by thrombin , 2022 .